Admit Therapeutics

ADmit Therapeutics, S

Biotech & Life Sciences

Sector

Seed

Stage

In vitro diagnostics

Model

01Company Overview

ADmit Therapeutics, S.L. is a company that has developed the MAP-AD® Test for the early detection of Alzheimer’s dementia and is currently in the commercialization stage.

02Backed By1 investor

CCClave Capital→

03Similar Companies

A

Is this your company? Claim your profile

Amprion

Biotech & Life Sciences

→

OB

Octave Bioscience

Biotech & Life Sciences

→

OB

Octave Bio

Biotech & Life Sciences

→

SH

Sampling Human

Healthcare & Digital Health

→

P

Pleno

Biotech & Life Sciences

→

04Startup DNA

9

signals

Sectors
Business Model
Technology